Monday , December 18 2017
Home / Letter From The Editor / Letter from the Editor:

Letter from the Editor:

This week we have an article about the use of glycated albumin for monitoring fluctuating and poorly controlled Type 2 diabetic patients. The authors talk about the use of this test and how it compares to the use of the A1c test for managing patients. Sounds like another test will start to be used for improved control, and one can only wonder if there will be a time when glycated albumin will become the newest diabetes diagnostic tool.

Speaking of A1c testing, I received 3 new studies this past week examining the use of A1c testing for the diagnosis of diabetes, and two of the editorials question whether or not a high A1c is enough to make the diagnosis. I looked back and found at least another 22 studies that were examining the same thing. It seems to me that these kinds of studies are a waste of time. The ADA says treat at 7% and ACE says treat at 6.5%, yet every time I look at a lab report the normal values range from 4.4% to 5.7%.

So it only seems logical that we should try to help our patients as soon as their A1c gets over 5.7. Maybe if we put as much effort into diabetes education in 2011 for all our patients as we do for these studies the outcomes would be better.

Happy Holidays to you from all of us at Diabetes In Control!

***

Many of you have helped patients avert diabetes disasters and we can all learn from them. If you have a “disaster averted” then send it in and if we use it in our new Diabetes Clinical Mastery Series you will receive a Visa Gift Card worth $50.00. Thank you again and congratulations to our readers who have been sent gift cards for their contributions! Click here to let us know the details. (You can use your name or remain anonymous if you prefer.)

Announcements:

dLife.com will be back for the New Year on Jan. 2, 2011. In the meantime, you can still check out their website anytime at www.dlife.com.

Please answer this week’s poll (in the right-hand column): Would you recommend a GLP-1 medication for pre-diabetic patients if the FDA approved it and lifestyle changes were not effective?

*****************************
We can make a difference!
*****************************

Check out this week’s “Test Your Diabetes Knowledge” question!

Dave Joffe, Editor-in-chief